-
A paracrine IGF1/IGF1R-PI3K signaling loop underlies resistance to CSF-1R inhibition in GBM
- Authors
- Bowman, Robert L.Quail, Daniela F.Joyce, Johanna A.
- Description
Summary from GEO: "Glioblastoma multiforme (GBM) is the most aggressive form of glioma, and is notorious for its terminal prognosis and lack of responsiveness to current treatment approaches. The brain tumor microenvironment (TME) represents a largely untapped reservoir of therapeutic target options in GBM. Here we have focused on the interplay between glioma cells and tumor-associated macrophages/...
- Subject
-
Drug Therapy, CombinationGlioblastomaMacrophagesNeoplasm Recurrence, LocalPhosphoinositide-3 Kinase InhibitorsReceptor, IGF Type 1Tumor Microenvironment
- Access Rights
- Free to All
-
Microenvironment-driven IGF-1R/PI3K signaling underlies acquired resistance to CSF1R inhibition in gliomas (CGH)
- Authors
- Bowman, Robert L.Quail, Daniela F.Schuhmacher, Alberto J.Joyce, Johanna A.
- Description
Summary form GEO: "Macrophages accumulate with glioblastoma multiforme (GBM) progression, and can be acutely targeted via inhibition of colony stimulating factor-1 receptor (CSF-1R) to regress high-grade tumors in animal models. However, whether and how resistance emerges in response to sustained CSF-1R blockade is unknown. Here, we investigate whether long-term CSF-1R inhibition can stably regress...
- Subject
-
Drug Therapy, CombinationGlioblastomaMacrophagesNeoplasm Recurrence, LocalPhosphoinositide-3 Kinase InhibitorsReceptor, IGF Type 1Tumor Microenvironment
- Access Rights
- Free to All
-
clonealign: 10X genomics chromium single-cell RNA-sequencing
- Description
Description from EGA: "10X genomics chromium single-cell RNA-sequencing of (i) patient derived triple negative breast cancer xenograft (ii) primary tumour and ascites ovarian cancer cell lines at tumour recurrence."
- Subject
-
Breast NeoplasmsGenomicsNeoplasm Recurrence, LocalOvarian NeoplasmsRNA-Seq
- Access Rights
- Application Required
-
Multi-region sequencing of tumor samples from PDAC patients
- Description
Description from EGA: "This study includes 542 of multi-region sampled whole exome sequencing data from 83 pancreatic cancer patients in 6 individual experiments : Kras wildtype, local recurrence, treatment-naive (MetomeV2), radiotherapy plus chemotherapy (Radome), chemotherapy-only group (Treatome) and Proj_B-100-478." Dataset is also accessioned as a study, associated with publication "The Evolutionary...
- Subject
-
ChemoradiotherapyDrug TherapyExome SequencingGenes, rasNeoplasm Recurrence, LocalPancreatic NeoplasmsRadiotherapy
- Access Rights
- Author approval required